ES2065303T1 - Procedimiento de diagnosis y vacuna especifica. - Google Patents
Procedimiento de diagnosis y vacuna especifica.Info
- Publication number
- ES2065303T1 ES2065303T1 ES92918970T ES92918970T ES2065303T1 ES 2065303 T1 ES2065303 T1 ES 2065303T1 ES 92918970 T ES92918970 T ES 92918970T ES 92918970 T ES92918970 T ES 92918970T ES 2065303 T1 ES2065303 T1 ES 2065303T1
- Authority
- ES
- Spain
- Prior art keywords
- diagnosis
- msd
- treatment
- specific vaccine
- procedure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000003745 diagnosis Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 210000002966 serum Anatomy 0.000 abstract 2
- 230000003612 virological effect Effects 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
LA INVENCION SE REFIERE A UNA VACUNA Y A SUEROS PARA EL TRATAMIENTO DE LA ENFERMEDAD MISTERIOSA DEL CERDO (MSD), A UN METODO PARA LA PRODUCCION DE LA VACUNA, A METODOS PARA EL DIAGNOSTICO DE LA MSD, UN AGENTE VIRAL QUE IMITARA LA "ENFERMEDAD MISTERIOSA DEL CERDO" Y ANTICUERPOS AL AGENTE VIRAL UTILES PARA EL DIAGNOSTICO Y TRATAMIENTO DE LA MSD. EL SUERO CONTIENE ANTICUERPOS DE MAMIFEROS QUE SON EFECTIVOS PARA EL TRATAMIENTO DE LA MSD.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74983991A | 1991-08-26 | 1991-08-26 | |
US76071391A | 1991-09-16 | 1991-09-16 | |
US86044492A | 1992-03-30 | 1992-03-30 |
Publications (3)
Publication Number | Publication Date |
---|---|
ES2065303T1 true ES2065303T1 (es) | 1995-02-16 |
ES2065303T3 ES2065303T3 (es) | 1997-02-16 |
ES2065303T5 ES2065303T5 (es) | 2001-05-01 |
Family
ID=27419388
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92918970T Expired - Lifetime ES2065303T5 (es) | 1991-08-26 | 1992-08-17 | Procedimiento de diagnosis y vacuna especifica. |
Country Status (15)
Country | Link |
---|---|
US (2) | US5683865A (es) |
EP (1) | EP0601062B2 (es) |
JP (4) | JP3473700B2 (es) |
KR (1) | KR100241221B1 (es) |
AT (1) | ATE144144T1 (es) |
AU (1) | AU2508492A (es) |
CA (1) | CA2116348C (es) |
DE (3) | DE69214657T2 (es) |
DK (1) | DK0601062T4 (es) |
ES (1) | ES2065303T5 (es) |
GR (3) | GR940300089T1 (es) |
HK (1) | HK1005014A1 (es) |
HU (1) | HU217105B (es) |
SG (1) | SG43852A1 (es) |
WO (1) | WO1993003760A1 (es) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2103460C (en) | 1991-06-06 | 2000-09-26 | Gert Wensvoort | Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
ATE144144T1 (de) * | 1991-08-26 | 1996-11-15 | James Edward Collins | Vakzine gegen und diagnosemethode für das schweine-unfruchtbarkeits- und atmungs-syndrom (suas) |
US6982160B2 (en) * | 1991-08-26 | 2006-01-03 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions that include SIRS virus |
US6042830A (en) * | 1992-08-05 | 2000-03-28 | Boehringer Ingelheim Vetmedica, Inc. | Viral agent associated with mystery swine disease |
US5846805A (en) * | 1991-08-26 | 1998-12-08 | Boehringer Ingelheim Animal Health, Inc. | Culture of swine infertility and respiratory syndrome virus in simian cells |
US6080570A (en) * | 1991-08-26 | 2000-06-27 | Boehringer Ingelheim Vetmedica, Inc. | Method of producing a vaccine for Swine Infertility and Respiratory Syndrome |
EP0610250B2 (en) * | 1991-10-14 | 2008-10-29 | Intervet International BV | Porcine reproductive respiratory syndrome (prrs) vaccine and diagnostic |
US6773908B1 (en) | 1992-10-30 | 2004-08-10 | Iowa State University Research Foundation, Inc. | Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
US6251397B1 (en) * | 1992-10-30 | 2001-06-26 | Iowa State University Research Foundation, Inc. | Proteins encoded by polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus and immunogenic compositions containing the same |
US5695766A (en) | 1992-10-30 | 1997-12-09 | Iowa State University Research Foundation | Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome |
US6592873B1 (en) * | 1992-10-30 | 2003-07-15 | Iowa State University Research Foundation, Inc. | Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids |
US6380376B1 (en) | 1992-10-30 | 2002-04-30 | Iowa State University Research Foundation | Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
CZ289743B6 (cs) * | 1993-02-08 | 2002-03-13 | Bayer Corporation | Izolát viru vepřového reprodukčního a respiračního syndromu PRRSV, způsob kultivace PRRSV, tkáňová kultura, způsob přípravy vakcíny a vakcína obsahující PRRSV izolát |
ES2165405T3 (es) * | 1994-04-11 | 2002-03-16 | Akzo Nobel Nv | Cepas de vacuna europeas del virus del sindrome reproductor y respiratorio porcino (prrsv). |
GB2289279B (en) * | 1994-05-13 | 1998-09-16 | Iberica Cyanamid | Diagnostic kits and vaccines containing recombinant PRRSV proteins |
DE69535061T2 (de) * | 1994-08-05 | 2007-01-25 | Regents Of The University Of Minnesota, Minneapolis | Virale nukleotidsequenz vr-2332 und nutzungsverfahren |
ES2102971B1 (es) * | 1996-01-25 | 1998-03-01 | Hipra Lab Sa | Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion. |
US5866401A (en) * | 1996-03-01 | 1999-02-02 | Schering Corporation | Porcine reproductive and respiratory syndrome vaccine |
US20040224327A1 (en) * | 1996-10-30 | 2004-11-11 | Meulenberg Johanna Jacoba Maria | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
EP0839912A1 (en) | 1996-10-30 | 1998-05-06 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
DE69837992T2 (de) | 1997-05-06 | 2008-03-20 | Boehringer Ingelheim Vetmedica Gmbh | Prrsv-antigene, die auf peptidsequenzen des prrs-virus basieren, für die verwendung als impfstoff und für diagnostische tests |
US7618797B2 (en) | 1998-12-22 | 2009-11-17 | Pfizer Inc | Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US7132106B2 (en) | 1998-12-22 | 2006-11-07 | Pfizer Inc. | Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US7691389B2 (en) | 1998-12-22 | 2010-04-06 | Pfizer Inc | Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
NZ501264A (en) | 1998-12-22 | 2001-09-28 | Pfizer Prod Inc | Polynucleotide DNA sequence encoding an infectious RNA molecule encoding a North American PRRS |
EP1157121B1 (en) | 1999-03-08 | 2013-04-24 | Boehringer Ingelheim Vetmedica GmbH | Prrsv replicon |
MXPA01010681A (es) | 1999-04-22 | 2003-08-20 | Us Agriculture | Vacuna de sindrome respiratorio y reproductiva porcina a base de ja-142 aislado. |
DK1255815T3 (da) * | 2000-02-08 | 2006-10-30 | Univ Minnesota | Porcint reproduktivt og respiratorisk syndromvirus til fremgangsmåder til anvendelse |
US6841364B2 (en) * | 2002-01-22 | 2005-01-11 | Protatek International, Inc. | Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof |
US7906311B2 (en) | 2002-03-20 | 2011-03-15 | Merial Limited | Cotton rat lung cells for virus culture |
AR049924A1 (es) * | 2004-06-18 | 2006-09-13 | Univ Minnesota | Identificacion de organismos viralmente infectados y vacunados |
US20080268426A1 (en) * | 2004-06-18 | 2008-10-30 | Regents Of The University Of Minnesota | Identifying virally infected and vaccinated organisms |
US7632636B2 (en) | 2004-09-21 | 2009-12-15 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome isolates and methods of use |
AU2006205852A1 (en) | 2005-01-13 | 2006-07-20 | Boehringer Ingelheim Vetmedica Gmbh | Improved PRRS vaccines |
CA2894069C (en) * | 2005-06-24 | 2019-02-26 | Regents Of The University Of Minnesota | Prrs viruses, infectious clones, mutants thereof, and methods of use |
US7666585B2 (en) * | 2007-06-15 | 2010-02-23 | Protatek International, Inc. | Construction of chimera PRRSV, compositions and vaccine preparations |
JP2010531143A (ja) * | 2007-06-25 | 2010-09-24 | サウス ダコタ ステート ユニバーシティー | 組換え北アメリカ1型ブタ生殖器呼吸器症候群ウイルス及び使用方法 |
WO2010025109A1 (en) * | 2008-08-25 | 2010-03-04 | Boehringer Ingelheim Vetmedia, Inc. | Vaccine against highly pathogenic porcine reproductive and respiratory syndrome (hp prrs) |
TWI627281B (zh) | 2009-09-02 | 2018-06-21 | 百靈佳殷格翰家畜藥品公司 | 降低pcv-2組合物殺病毒活性之方法及具有改良免疫原性之pcv-2組合物 |
UA108902C2 (uk) | 2010-11-10 | 2015-06-25 | Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування | |
US9944902B2 (en) | 2011-02-17 | 2018-04-17 | Boehringer Ingelheim Vetmedica Gmbh | Commercial scale process for production of PRRSV |
PL2675475T3 (pl) | 2011-02-17 | 2015-12-31 | Boehringer Ingelheim Vetmedica Gmbh | Nowy europejski szczep prrs |
US9187731B2 (en) | 2011-07-29 | 2015-11-17 | Boehringer Ingelheim Vetmedica Gmbh | PRRS virus inducing type I interferon in susceptible cells |
US9315781B2 (en) | 2011-07-29 | 2016-04-19 | Boehringer Ingelheim Vetmedica Gmbh | Infectious CDNA clone of european PRRS virus and uses thereof |
UA114503C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
US9120859B2 (en) | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
UA114504C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
WO2013173443A1 (en) | 2012-05-17 | 2013-11-21 | Zoetis Llc | Effective vaccination against porcine reproductive and respiratory syndrome (prrs) virus prior to weaning |
EP2968513A2 (en) | 2013-03-15 | 2016-01-20 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use |
KR101502360B1 (ko) * | 2013-03-20 | 2015-03-25 | 주식회사 옵티팜 | 신규한 국내형 돼지생식기호흡기증후군 바이러스 |
US9920302B2 (en) | 2015-08-31 | 2018-03-20 | Boehringer Ingelheim Vetmedica Gmbh | Pestivirus vaccines for congenital tremors |
US10188725B2 (en) | 2015-12-14 | 2019-01-29 | Elanco Us Inc. | Hybrid core feline vaccines |
BR112019012158A2 (pt) | 2016-12-14 | 2019-11-12 | Zoetis Services Llc | vacinação eficaz contra cepas europeias de vírus da síndrome reprodutiva e respiratória suína (prrs) antes do desmame |
US11701419B2 (en) | 2019-04-04 | 2023-07-18 | Boehringer Ingelheim Animal Health USA Inc. | Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof |
RU2731474C1 (ru) * | 2020-02-26 | 2020-09-03 | Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский ветеринарный институт патологии, фармакологии и терапии" (ФГБНУ "ВНИВИПФиТ") | Способ диагностики скрыто протекающего воспалительного процесса в репродуктивных органах свиноматок |
BR112023001324A2 (pt) | 2020-07-24 | 2023-02-14 | Boehringer Ingelheim Animal Health Usa Inc | Combinação de vacina de suíno |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DD145705A1 (de) * | 1979-08-31 | 1981-01-07 | Peter Solisch | Herstellungsverfahren von organspezifischen retrovirusimmunpraeparaten fuer prophylaxe,therapie und diagnostik |
ZA864879B (en) * | 1985-07-08 | 1987-03-25 | Wallone Region | Vaccines and diagnostics derived from boving diarrhoea virus |
NZ222465A (en) * | 1986-11-07 | 1992-11-25 | Pasteur Institut | Nanb (non a, non b hepatitis viral) antigen |
DE3833925A1 (de) * | 1988-03-11 | 1989-09-21 | Inst Angewandte Biotechnologie | Verfahren und herstellung von virus und viralem antigen und vorrichtung hierzu |
CA2103460C (en) * | 1991-06-06 | 2000-09-26 | Gert Wensvoort | Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
ATE144144T1 (de) * | 1991-08-26 | 1996-11-15 | James Edward Collins | Vakzine gegen und diagnosemethode für das schweine-unfruchtbarkeits- und atmungs-syndrom (suas) |
US6042830A (en) † | 1992-08-05 | 2000-03-28 | Boehringer Ingelheim Vetmedica, Inc. | Viral agent associated with mystery swine disease |
-
1992
- 1992-08-17 AT AT92918970T patent/ATE144144T1/de active
- 1992-08-17 DE DE1992614657 patent/DE69214657T2/de not_active Expired - Lifetime
- 1992-08-17 WO PCT/US1992/006873 patent/WO1993003760A1/en active Application Filing
- 1992-08-17 DE DE1992614657 patent/DE69214657T4/de not_active Expired - Lifetime
- 1992-08-17 HU HU9400560A patent/HU217105B/hu unknown
- 1992-08-17 CA CA 2116348 patent/CA2116348C/en not_active Expired - Lifetime
- 1992-08-17 DK DK92918970T patent/DK0601062T4/da active
- 1992-08-17 EP EP92918970A patent/EP0601062B2/en not_active Expired - Lifetime
- 1992-08-17 KR KR1019940700576A patent/KR100241221B1/ko not_active IP Right Cessation
- 1992-08-17 AU AU25084/92A patent/AU2508492A/en not_active Abandoned
- 1992-08-17 DE DE1992918970 patent/DE601062T1/de active Pending
- 1992-08-17 ES ES92918970T patent/ES2065303T5/es not_active Expired - Lifetime
- 1992-08-17 SG SG1996002526A patent/SG43852A1/en unknown
- 1992-08-17 JP JP50448593A patent/JP3473700B2/ja not_active Expired - Lifetime
-
1994
- 1994-12-30 GR GR940300089T patent/GR940300089T1/el unknown
-
1995
- 1995-02-24 US US08/394,226 patent/US5683865A/en not_active Expired - Lifetime
- 1995-06-07 US US08/488,286 patent/US5677429A/en not_active Expired - Lifetime
-
1996
- 1996-12-30 GR GR960403673T patent/GR3022194T3/el unknown
-
1998
- 1998-05-14 HK HK98104158A patent/HK1005014A1/xx not_active IP Right Cessation
-
2001
- 2001-02-20 GR GR20010400273T patent/GR3035442T3/el unknown
-
2002
- 2002-10-25 JP JP2002310716A patent/JP3722794B2/ja not_active Expired - Lifetime
-
2003
- 2003-07-31 JP JP2003204230A patent/JP3566279B2/ja not_active Expired - Lifetime
-
2005
- 2005-07-29 JP JP2005220209A patent/JP3878647B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2065303T3 (es) | Procedimiento de diagnosis y vacuna especifica. | |
ES2089316T3 (es) | Agente viral asociado con la enfermedad porcina misteriosa (mystery swine desease). | |
KR930702026A (ko) | 자기항원의 경구 투여에 의한 자기면역 질병의 치료 | |
ES2190784T3 (es) | Supresion de enfermedades autoinmunes por antigenos espectadores. | |
ES2144398T3 (es) | Tratamiento mejorado de enfermedades autoinmunes mediante la administracion en aerosol de autoantigenos. | |
DE3854741T2 (de) | Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen. | |
ATE411043T1 (de) | Verfahren von dna-impfung | |
WO1996010419A3 (en) | Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule | |
CO5280094A1 (es) | Un analogo de a o app y una composicion inmunogenica que comprende dicho analogo | |
PT912898E (pt) | Metodo imunologico de deteccao de anticorpos dirigidos contra a transglutaminase (ttg) utilizacao de ttg para o diagnostico e controlo de terapia assim como agente farmaceutico oral contendo ttg | |
DK235687A (da) | Tilberedninger til syntese af prostaglandiner og hydroxyfedtsyrer i biologiske systemer og anvendelse deraf | |
ES2102368T3 (es) | Conjugado de vacuna para el tratamiento de las enfermedades de las aves. | |
FI875245A (fi) | Foerfarande foer oekande av utsoendringen av adenosin. | |
DE69030099T2 (de) | Verfahren zur herstellung von impfstoffen oder toxoiden | |
DK16087D0 (da) | Mastitis-vaccine | |
ATE39055T1 (de) | Verfahren zur immunisierung von schweinen gegen die aujeszky-krankheit. | |
PT88913A (pt) | Processo para a preparacao da proteina pp4-x anticoagulante | |
BR9814556A (pt) | Cepas isoladas de staphylococcus aureus e vacinas fabricadas a partir das mesmas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 601062 Country of ref document: ES |